Title | Type | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Psychopharmacology | journal | 1.798 Q1 | 214 | 370 | 997 | 18890 | 4002 | 948 | 3.64 | 51.05 | |
52 | Journal of Gene Medicine | journal | 1.054 Q1 | 100 | 159 | 242 | 7732 | 941 | 236 | 3.60 | 48.63 | |
53 | Antiviral Research | journal | 1.113 Q1 | 151 | 92 | 255 | 3664 | 916 | 253 | 3.57 | 39.83 | |
54 | Biochemical Pharmacology | journal | 1.398 Q1 | 220 | 475 | 1284 | 21122 | 4540 | 1241 | 3.57 | 44.47 | |
55 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.240 Q1 | 82 | 12 | 44 | 1900 | 171 | 43 | 3.57 | 158.33 | |
56 | Topics in antiviral medicine | journal | 1.428 Q1 | 46 | 17 | 27 | 290 | 93 | 27 | 3.44 | 17.06 | |
57 | British Journal of Pharmacology | journal | 1.467 Q1 | 244 | 413 | 1676 | 18647 | 5890 | 1639 | 3.36 | 45.15 | |
58 | Drug and Alcohol Dependence | journal | 1.533 Q1 | 187 | 148 | 419 | 6289 | 1487 | 410 | 3.35 | 42.49 | |
59 | Pharmacogenomics Journal | journal | 1.284 Q1 | 95 | 58 | 174 | 2214 | 586 | 150 | 3.35 | 38.17 | |
60 | Clinical Therapeutics | journal | 1.009 Q1 | 150 | 203 | 563 | 7660 | 1970 | 478 | 3.34 | 37.73 | |
61 | Toxicological Sciences | journal | 1.314 Q1 | 207 | 297 | 777 | 11408 | 2535 | 744 | 3.32 | 38.41 | |
62 | Receptors and Channels | journal | 1.369 Q1 | 44 | 19 | 92 | 868 | 279 | 85 | 3.28 | 45.68 | |
63 | Infectious Disorders - Drug Targets | journal | 0.956 Q1 | 61 | 31 | 90 | 2811 | 285 | 85 | 3.21 | 90.68 | |
64 | Current Opinion in Molecular Therapeutics | journal | 1.175 Q1 | 67 | 87 | 263 | 4579 | 816 | 240 | 3.20 | 52.63 | |
65 | Journal of Immunotherapy | journal | 47 | 3 | 91 | 130 | 313 | 90 | 3.13 | 43.33 | ||
66 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.068 Q1 | 99 | 18 | 32 | 2144 | 94 | 31 | 3.09 | 119.11 | |
67 | Therapeutic Drug Monitoring | journal | 0.753 Q2 | 102 | 119 | 336 | 3278 | 972 | 320 | 3.09 | 27.55 | |
68 | Toxicology | journal | 0.979 Q1 | 176 | 260 | 805 | 9558 | 2307 | 789 | 3.01 | 36.76 | |
69 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.216 Q4 | 50 | 17 | 29 | 2216 | 24 | 29 | 3.00 | 130.35 | |
70 | Journal of Computer-Aided Molecular Design | journal | 1.063 Q1 | 119 | 60 | 206 | 2287 | 666 | 206 | 3.00 | 38.12 | |
71 | International Journal of Neuropsychopharmacology | journal | 1.338 Q1 | 125 | 70 | 155 | 2716 | 476 | 138 | 2.95 | 38.80 | |
72 | Chemical Research in Toxicology | journal | 1.342 Q1 | 177 | 197 | 576 | 9101 | 1989 | 574 | 2.94 | 46.20 | |
73 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.741 Q1 | 69 | 117 | 153 | 4033 | 437 | 152 | 2.91 | 34.47 | |
74 | CNS Drug Reviews | journal | 0.793 Q2 | 64 | 23 | 71 | 1705 | 216 | 71 | 2.88 | 74.13 | |
75 | Chemico-Biological Interactions | journal | 0.820 Q2 | 144 | 87 | 486 | 3757 | 996 | 481 | 2.87 | 43.18 | |
76 | Tetrahedron | journal | 1.466 Q1 | 236 | 1211 | 3300 | 52315 | 9848 | 3286 | 2.83 | 43.20 | |
77 | Journal of Studies on Alcohol and Drugs | journal | 1.480 Q1 | 137 | 99 | 317 | 3672 | 928 | 309 | 2.79 | 37.09 | |
78 | Progress in Medicinal Chemistry | journal | 1.638 Q1 | 38 | 7 | 27 | 1827 | 95 | 23 | 2.79 | 261.00 | |
79 | Journal of Clinical Pharmacology | journal | 0.722 Q2 | 130 | 146 | 468 | 5026 | 1254 | 464 | 2.75 | 34.42 | |
80 | Toxicology and Applied Pharmacology | journal | 1.131 Q1 | 189 | 243 | 612 | 14599 | 1887 | 598 | 2.75 | 60.08 | |
81 | Pharmaceutical Research | journal | 1.099 Q1 | 229 | 294 | 802 | 9797 | 2373 | 798 | 2.74 | 33.32 | |
82 | Pharmacology Biochemistry and Behavior | journal | 1.030 Q1 | 148 | 283 | 850 | 12728 | 2221 | 845 | 2.74 | 44.98 | |
83 | Toxicology Letters | journal | 1.007 Q1 | 163 | 308 | 728 | 10463 | 2081 | 710 | 2.74 | 33.97 | |
84 | Current Drug Targets: Inflammation and Allergy | journal | 0.856 Q2 | 53 | 57 | 53 | 5459 | 143 | 53 | 2.70 | 95.77 | |
85 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.988 Q1 | 150 | 163 | 443 | 8000 | 1198 | 437 | 2.70 | 49.08 | |
86 | Tetrahedron Letters | journal | 1.300 Q1 | 181 | 2123 | 6648 | 56322 | 17545 | 6647 | 2.70 | 26.53 | |
87 | European Journal of Pharmacology | journal | 0.989 Q1 | 203 | 775 | 2292 | 31548 | 6186 | 2286 | 2.69 | 40.71 | |
88 | Molecular Diagnosis and Therapy | journal | 68 | 68 | 170 | 3725 | 393 | 167 | 2.68 | 54.78 | ||
89 | NeuroToxicology | journal | 0.872 Q2 | 133 | 99 | 242 | 5035 | 596 | 241 | 2.67 | 50.86 | |
90 | Current Opinion in Investigational Drugs | journal | 0.780 Q2 | 83 | 158 | 449 | 7594 | 1156 | 418 | 2.66 | 48.06 | |
91 | PharmacoEconomics | journal | 0.907 Q1 | 118 | 121 | 318 | 5062 | 947 | 307 | 2.65 | 41.83 | |
92 | Food and Chemical Toxicology | journal | 0.877 Q1 | 203 | 209 | 505 | 8623 | 1303 | 491 | 2.63 | 41.26 | |
93 | Vascular Pharmacology | journal | 1.167 Q1 | 108 | 36 | 124 | 1200 | 323 | 119 | 2.63 | 33.33 | |
94 | Current Pharmaceutical Biotechnology | journal | 0.790 Q1 | 97 | 62 | 94 | 4150 | 238 | 87 | 2.62 | 66.94 | |
95 | Steroids | journal | 0.849 Q2 | 114 | 103 | 373 | 3356 | 949 | 370 | 2.61 | 32.58 | |
96 | Alcohol: Clinical and Experimental Research | journal | 171 | 267 | 850 | 12422 | 2497 | 846 | 2.60 | 46.52 | ||
97 | Expert Opinion on Therapeutic Targets | journal | 0.930 Q1 | 106 | 54 | 162 | 4953 | 365 | 155 | 2.60 | 91.72 | |
98 | Expert Opinion on Biological Therapy | journal | 0.928 Q1 | 102 | 170 | 292 | 13679 | 799 | 280 | 2.59 | 80.46 | |
99 | Journal of Biomolecular Screening | journal | 0.902 Q2 | 86 | 68 | 166 | 1724 | 429 | 160 | 2.59 | 25.35 | |
100 | British Journal of Clinical Pharmacology | journal | 0.904 Q2 | 167 | 219 | 590 | 5397 | 1657 | 516 | 2.57 | 24.64 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®